One-Year Effectiveness and Safety of Vedolizumab Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Cohort Study
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14167
Full Text
Open PDFAbstract
Available in full text
Date
June 8, 2017
Authors
Publisher
Wiley